ACCESS THE LATEST RESEARCH AND INSIGHTS
“Free Cash Growth Machine” Should be a Core Holding
Also inside: A 50-Year Overnight Success Story in Renewable Natural Gas Could Gain 32%.
“Free Cash Growth Machine” Should be a Core Holding
Also inside: A 50-Year Overnight Success Story in Renewable Natural Gas Could Gain 32%.
A MODEL GROWTH BY ACQUISITION COMPANY
Today’s new Digest features a company that has the growth by acquisition model down pat with a 3,000%+ stock gain the last 15 years.
A MODEL GROWTH BY ACQUISITION COMPANY
Today’s new Digest features a company that has the growth by acquisition model down pat with a 3,000%+ stock gain the last 15 years.
MEDEXUS CEO INTERVIEW: GROWING FAST, EBITDA POSITIVE, $27 MILLION CASH
Watch our video interview with Ken d’Entremont, CEO of Medexus Pharmaceuticals, to find out what you may be missing with this fast growing company.
MEDEXUS CEO INTERVIEW: GROWING FAST, EBITDA POSITIVE, $27 MILLION CASH
Watch our video interview with Ken d’Entremont, CEO of Medexus Pharmaceuticals, to find out what you may be missing with this fast growing company.
“The Best Retail Stock to Buy Today”
Also inside: New Research on a Cash-Rich Pharma That Has 65% Upside.
“The Best Retail Stock to Buy Today”
Also inside: New Research on a Cash-Rich Pharma That Has 65% Upside.
CELEBRITY FACTOR DRIVING THIS RETAIL STOCK
What’s the best retail stock to buy? We’ve got it in today’s new Digest, which we’ll publish at 7 pm eastern time, accompanied by the usual email alert.
CELEBRITY FACTOR DRIVING THIS RETAIL STOCK
What’s the best retail stock to buy? We’ve got it in today’s new Digest, which we’ll publish at 7 pm eastern time, accompanied by the usual email alert.